Alemtuzumab

Alemtuzumab is a medication primarily used to treat certain autoimmune diseases like multiple sclerosis and some forms of leukemia. It works by targeting specific immune cells, leading to their destruction. This helps reduce inflammation and prevents the immune system from attacking the body’s own tissues. Because it alters immune function, it can increase the risk of infections, so patients are monitored closely. Alemtuzumab is typically administered through an infusion in a healthcare setting, and its effects can last for an extended period, making it a significant treatment option for those conditions.